References
- WangLLiMZhangNFolate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapyInt J Nanomedicine201273281329422802688
- CardenCPBanerjiUKayeSBWorkmanPde BonoJSFrom darkness to light with biomarkers in early clinical trials of cancer drugsClin Pharmacol Ther200985213113319151637
- CaoPMairaSMGarcia-EcheverriaCHedleyDWActivity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenograftsBr J Cancer200910081267127619319133
- LiBXuHLiZBypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assembliesInt J Nanomedicine2012718719722275834
- CaiL-LLiuPLiXRGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cellsInt J Nanomedicine201163499350822282676
- KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
- LotanRRazALectins in cancer cellsAnn N Y Acad Sci19885513853963072905
- YangFTangQZhongXSurface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticlesInt J Nanomedicine2012734993508
- ZhengSLiXZhangYPEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunctionInt J Nanomedicine201273939394922915845
- ZhangLWebsterTJPoly-lactic-glycolic-acid surface nanotopographies selectively decrease breast adenocarcinoma cell functionsNanotechnology2012231515510122436863
- ZhangLChunYWWebsterTJDecreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapiesInt J Nanomedicine2010526927520517474
- ZhangLWebsterTJDecreased lung carcinoma cell functions on select polymer nanometer surface featuresJ Biomed Mater Res A201110019410221987490
References
- FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
- SchroederAHellerDATreating metastatic cancer with nanotechnologyNat Rev Cancer2012121395022193407
- SiddiquiIAAdhamiVMImpact of nanotechnology in cancer: emphasis on nanochemopreventionInt J Nanomedicine2012759160522346353
- WangLLiuZDocetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activityInt J Pharm20114131–219420121540085
- RanganathanRMadanmohanSNanomedicine: towards development of patient-friendly drug-delivery systems for oncological applicationsInt J Nanomedicine201271043106022403487
- WangLLiMFolate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapyInt J Nanomedicine201273281329422802688
- EgusquiaguirreSPIgartuaMNanoparticle delivery systems for cancer therapy: advances in clinical and preclinical researchClin Transl Oncol2012142839322301396
- KhalilIAKogureKUptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev2006581324516507881